Quick Answer
KYNTRA BIO, INC. reported Stockholders Equity of -$30.04 million for fiscal year 2025.
KYNTRA BIO, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$30.04M | +86.7% |
| 2024 | -$225.60M | -10.5% |
| 2023 | -$204.17M | -852.0% |
| 2022 | -$21.45M | -110.3% |
| 2021 | $209.15M | -50.5% |
| 2020 | $422.18M | -18.2% |
| 2019 | $516.13M | +1.4% |
| 2018 | $509.20M | -3.6% |
| 2017 | $528.47M | +239.1% |
| 2016 | $155.84M | -12.2% |
| 2015 | $177.55M | -19.8% |
| 2014 | $221.41M | +464.0% |
| 2013 | -$60.83M | -31.5% |
| 2012 | -$46.25M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$17.03M | +93.0% | +92.4% |
| June 30, 2025 | -$223.00M | +4.0% | -2.8% |
| March 31, 2025 | -$216.90M | +4.9% | +3.9% |
| December 31, 2024 | -$225.60M | -10.5% | +7.4% |
| September 30, 2024 | -$243.67M | -55.0% | -4.9% |
| June 30, 2024 | -$232.34M | -127.2% | -1.8% |
| March 31, 2024 | -$228.12M | -367.0% | -11.7% |
| December 31, 2023 | -$204.17M | -852.0% | -29.9% |
- KYNTRA BIO, INC. showed an increase of +86.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, KYNTRA BIO, INC.’s stockholders equity has grown by 35.1% (from -$46.25 million to -$30.04 million).
- The most recent figure is from KYNTRA BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: